(Q39748423)

14 September 2017

1 reference

title

The current status of monoclonal antibodies in the diagnosis and therapy of cancer (English)

1 reference

14 September 2017

Lowder JN

1

1 reference

14 September 2017

language of work or name

1 reference

1 October 1986

1 reference

Current Problems in Cancer

14 September 2017

published in

1 reference

14 September 2017

volume

10

1 reference

14 September 2017

issue

10

1 reference

14 September 2017

page(s)

485-551

1 reference

Continuous cultures of fused cells secreting antibody of predefined specificity

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Hybridomas as a source of antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Monoclonal antibodies. A new technique for producing serologic reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Electric field-induced cell-to-cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Tailor-made monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Recombinant antibodies possessing novel effector functions

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Univalent antibodies kill tumour cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Covalent attachment of chelating groups to macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Specific immunosuppression by immunotoxins containing daunomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Antibodies to membrane structures that distinguish suppressor/cytotoxic and helper T lymphocyte subpopulations block the mixed leukocyte reaction in man

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Functional activities of antibodies against brain-associated T cell antigens. I. Induction of T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Effects of in vivo administration of monoclonal antibodies specific for human T cell subpopulations on the immune system in a rhesus monkey model

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions: effect of anti-T11 monoclonal antibody on functional capabilities of alloreactive T cell clones.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Pilot trial of murine monoclonal antibodies in patients with advanced melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Specific Antigen in Serum of Patients with Colon Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

The human immune response to the OKT3 monoclonal antibody is oligoclonal

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Mechanism of action of the toxic lectins abrin and ricin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

The intracellular traffic of immunologically active molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Pseudomonas exotoxin-anti-TAC. Cell-specific immunotoxin active against cells expressing the human T cell growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Receptor-mediated endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Immunotoxins: A New Approach to Cancer Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Potential applications of monoclonal antibodies in cancer diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Phase I–II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Treatment of Resistant Malignant Lymphoma with Cyclophosphamide, Total Body Irradiation, and Transplantation of Cryopreserved Autologous Marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Lethal GVHD Across Minor Histocompatibility Barriers: Nature of the Effector Cells and Role of the H-2 Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Fatal Epstein-Barr-Virus-Associated Proliferation of Donor B Cells After Treatment of Acute Graft-Versus-Host Disease with a Murine Anti-T-Cell Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Labelled Antibodies and Immunological Assay Systems

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Third Gordon Hamilton-Fairley Memorial Lecture. Tumour markers—Where do we go from here?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Prognostic Significance of a Decline in Serum Human Chorionic Gonadotropin Levels After Initial Chemotherapy for Advanced Germ-Cell Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Diagnosis of human lymphoma with monoclonal antileukocyte antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Dual immunofluorescence - new frontiers in cell analysis and sorting

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Fluorescent phycobiliprotein conjugates for analyses of cells and molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Immunoglobulin gene rearrangement as a diagnostic criterion of B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Detection of Small Numbers of Monoclonal B Lymphocytes in the Blood of Patients with Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Detection of B-cell lymphoma in peripheral blood by DNA hybridisation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Tumor-associated antigens--an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Imaging of T-cell lymphoma by radiolabelled monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

Monoclonal antibodies in the lymphatics: selective delivery to lymph node metastases of a solid tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980012-5

7 January 2021

10.1016/S0147-0272(86)80012-5

Identifiers

DOI

1 reference

14 September 2017

1 reference